These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6307186)

  • 1. [Adriamycin, cardiotoxicity--a case report].
    Okuma K; Ota K
    Gan To Kagaku Ryoho; 1982 May; 9(5):936-41. PubMed ID: 6307186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
    Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of cardiotoxicity in new anthracycline analog ME 2303. ME 2303 Study Group].
    Okuma K; Ariyoshi Y; Wakui A; Ogawa M; Furue H; Niitani H; Shimoyama M; Majima H; Taguchi T; Kimura I
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1143-9. PubMed ID: 2053773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adriamycin and mitomycin C: possible synergistic cardiotoxicity.
    Buzdar AU; Legha SS; Tashima CK; Hortobagyi GN; Yap HY; Krutchik AN; Luna MA; Blumenschein GR
    Cancer Treat Rep; 1978 Jul; 62(7):1005-8. PubMed ID: 688243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients.
    Ardizzoni A; Pronzato P; Conte PF; Rosso R
    Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute cardiotoxicity of anthracyclines--analysis by using Holter ECG].
    Okuma K; Furuta I; Ota K
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):902-11. PubMed ID: 6202243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ECG changes in adriamycin therapy].
    Pötzi P; Huber J; Kühböck J; Weber H
    Acta Med Austriaca Suppl; 1979; 6():339-41. PubMed ID: 299225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD)].
    Adam Z; Elbl L; Vorlícek J; Hájek R; Tomíska M; Hejlová N; Králová E; Novotná H
    Vnitr Lek; 1994 Aug; 40(8):506-12. PubMed ID: 7941437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of adriamycin for advanced breast cancer (3)--a joint study by 26 institutes on the CAF and CMcF treatment].
    Kubo K; Abe O; Izuo M; Enomoto K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2523-31. PubMed ID: 6689117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin].
    Okuma K; Furuta I; Ota K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):502-8. PubMed ID: 6703724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiotoxicity of mitoxantrone].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3040-5. PubMed ID: 3464231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiochemotherapy in the liver metastases of cystosarcoma phyllodes].
    Riepl M; Strnad V
    Strahlenther Onkol; 1994 Nov; 170(11):668-72. PubMed ID: 7974183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of acute cardiotoxicity of anti-cancer agents-- analysis using Holter ECG monitoring].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1893-900. PubMed ID: 3164181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac side effects of 5-fluorouracil].
    May D; Wandl U; Becher R; Niederle N; Schmidt CG
    Dtsch Med Wochenschr; 1990 Apr; 115(16):618-21. PubMed ID: 2328669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective effect of CoQ 10 administration on cardial toxicity in FAC therapy].
    Takimoto M; Sakurai T; Kodama K; Yokoi H; Suzuki Y; Enomoto K; Okada N
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):116-21. PubMed ID: 7184359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of cardiotoxicity of doxorubicin (Adriamycin) using cardioxane (ICRF-187, dexrazoxane) in the combination chemotherapy of disseminated breast cancer].
    Gershanovich ML; Moiceenko VM; Orlova RV
    Vopr Onkol; 1993; 39(1-3):26-32. PubMed ID: 8073671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial.
    Takada T; Nimura Y; Katoh H; Nagakawa T; Nakayama T; Matsushiro T; Amano H; Wada K
    Hepatogastroenterology; 1998; 45(24):2020-6. PubMed ID: 9951857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
    Ninomiya K; Sekido S; Araki T
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
    Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.